retatrutide 2025 trial results Phase 3: 60% Achieved Surgical-Level Weight Loss Retatrutide Blood Sugar Results: 2.02%

Diabetologia 66 , 18691881 (2023)

If you have not had bloodwork done recently, schedule it before your GLP-1 appointment

Knerr PJ, Mowery SA, Douros JD, Premdjee B, Hjllund KR, He Y, et al

At Abundant Life Healthcare, many of our patients have found success with Ozempic due to its significant weight-loss benefits, often surpassing outcomes seen with other GLP-1 receptor agonists like liraglutide (Saxenda), dulaglutide (Trulicity), or exenatide (Byetta, Bydureon)

Why Researchers Choose GLP-1-SEMA Sema has become one of the most widely researched GLP-1 receptor agonists because of its prolonged biological activity and extensive scientific literature

As for significant weight management results, those tend to show up after a few months of consistent effort